Tridoss Laboratories Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 08-12-2024
- Paid Up Capital ₹ 9.15 Cr
as on 08-12-2024
- Company Age 43 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 17.05 Cr
as on 08-12-2024
- Revenue -2.43%
(FY 2023)
- Profit 756.08%
(FY 2023)
- Ebitda -21.32%
(FY 2023)
- Net Worth 5.71%
(FY 2023)
- Total Assets 7.71%
(FY 2023)
About Tridoss Laboratories
The Corporate was formerly known as Tridoss Laboratories Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.15 Cr.
The company currently has active open charges totaling ₹17.05 Cr.
Akhtar Shamsi and Nargis Shamsi serve as directors at the Company.
- CIN/LLPIN
U24230MH1981PTC025373
- Company No.
025373
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Oct 1981
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Tridoss Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akhtar Shamsi  | Director | 02-Sep-2002 | Current |
| Nargis Shamsi | Director | 02-Sep-2002 | Current |
Financial Performance and Corporate Structure Insights of Tridoss Laboratories.
Tridoss Laboratories Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.43% decrease. The company also saw a substantial improvement in profitability, with a 756.08% increase in profit. The company's net worth moved up by a moderate rise of 5.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tridoss Laboratories?
In 2023, Tridoss Laboratories had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Yurt Estate Development Private LimitedActive 29 years 4 months
Akhtar Shamsi and Nargis Shamsi are mutual person
- Caudilo Estate Development Private LimitedActive 27 years 6 months
Akhtar Shamsi and Nargis Shamsi are mutual person
- Jinita Estate Development Private LimitedActive 27 years 6 months
Akhtar Shamsi and Nargis Shamsi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Standard Chartered Bank Creation Date: 19 Jun 1997 | ₹9.50 Cr | Open |
Banque Nationale De Paris Creation Date: 22 Mar 1996 | ₹6.00 Cr | Open |
The British Bank Of The Middle Eat Creation Date: 21 Jun 1993 | ₹1.25 Cr | Open |
How Many Employees Work at Tridoss Laboratories?
Unlock and access historical data on people associated with Tridoss Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tridoss Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tridoss Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
